These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8931121)

  • 21. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.
    Edgemond WS; Hillard CJ; Falck JR; Kearn CS; Campbell WB
    Mol Pharmacol; 1998 Jul; 54(1):180-8. PubMed ID: 9658204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anandamide may mediate sleep induction.
    Mechoulam R; Fride E; Hanus L; Sheskin T; Bisogno T; Di Marzo V; Bayewitch M; Vogel Z
    Nature; 1997 Sep; 389(6646):25-6. PubMed ID: 9288961
    [No Abstract]   [Full Text] [Related]  

  • 26. Cannabinoid properties of methylfluorophosphonate analogs.
    Martin BR; Beletskaya I; Patrick G; Jefferson R; Winckler R; Deutsch DG; Di Marzo V; Dasse O; Mahadevan A; Razdan RK
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1209-18. PubMed ID: 10945879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid.
    Wise ML; Soderstrom K; Murray TF; Gerwick WH
    Experientia; 1996 Jan; 52(1):88-92. PubMed ID: 8575565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease.
    Navarro M; Rodríguez de Fonseca F
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):379-85. PubMed ID: 9974172
    [No Abstract]   [Full Text] [Related]  

  • 30. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.
    Bisogno T; Berrendero F; Ambrosino G; Cebeira M; Ramos JA; Fernandez-Ruiz JJ; Di Marzo V
    Biochem Biophys Res Commun; 1999 Mar; 256(2):377-80. PubMed ID: 10079192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal transduction of eicosanoid CB1 receptor ligands.
    Howlett AC; Mukhopadhyay S; Shim JY; Welsh WJ
    Life Sci; 1999; 65(6-7):617-25. PubMed ID: 10462062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.
    Kimura T; Ohta T; Watanabe K; Yoshimura H; Yamamoto I
    Biol Pharm Bull; 1998 Mar; 21(3):224-6. PubMed ID: 9556149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
    Paria BC; Das SK; Dey SK
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between eicosanoids and cannabinoids. Are eicosanoids cannabimimetic agents?
    Burstein SH; Young JK; Wright GE
    Biochem Pharmacol; 1995 Nov; 50(11):1735-42. PubMed ID: 8615850
    [No Abstract]   [Full Text] [Related]  

  • 38. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas.
    Ng EW; Aung MM; Abood ME; Martin BR; Razdan RK
    J Med Chem; 1999 Jun; 42(11):1975-81. PubMed ID: 10354405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.
    Jarrahian A; Manna S; Edgemond WS; Campbell WB; Hillard CJ
    J Neurochem; 2000 Jun; 74(6):2597-606. PubMed ID: 10820223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
    Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.